Psyrx Bio-Tech (IL:PSRX)
TASE:PSRX
PSRX Stock Chart & Stats
199.50
-0.10(-6.00%)
At close: 4:00 PM EST
199.50
-0.10(-6.00%)
Day’s Range― - ―
52-Week Range80.00 - 388.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)139.30K
Market Cap
₪13.77M
Enterprise Value-62.93K
Total Cash (Recent Filing)₪203.69K
Total Debt (Recent Filing)₪0.00
Price to Earnings (P/E)1.1
Beta-0.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding14,082,396
10 Day Avg. Volume38,668
30 Day Avg. Volume139,298
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.05
Price to Sales (P/S)-2.81
P/FCF Ratio-0.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PSRX FAQ
What was Psyrx Bio-Tech’s price range in the past 12 months?
Psyrx Bio-Tech lowest stock price was 80.00 and its highest was 388.00 in the past 12 months.
What is Psyrx Bio-Tech’s market cap?
Psyrx Bio-Tech’s market cap is ₪13.77M.
When is Psyrx Bio-Tech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Psyrx Bio-Tech’s earnings last quarter?
Currently, no data Available
Is Psyrx Bio-Tech overvalued?
According to Wall Street analysts Psyrx Bio-Tech’s price is currently Overvalued.
Does Psyrx Bio-Tech pay dividends?
Psyrx Bio-Tech does not currently pay dividends.
What is Psyrx Bio-Tech’s EPS estimate?
Psyrx Bio-Tech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psyrx Bio-Tech have?
Psyrx Bio-Tech has 14,082,396 shares outstanding.
What happened to Psyrx Bio-Tech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Psyrx Bio-Tech?
Currently, no hedge funds are holding shares in IL:PSRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Psyrx Bio-Tech
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.